Background illustration for clinical trials search

Paid Clinical Trials Denver

Discover 1,569 paid clinical trials in Denver, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

for
Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1,
Location: Centennial CO, Scottsdale AZ, Litchfield Park AZ,
Sponsor: ADARx Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06960213

Phase 3, Recruiting

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

for
Acute Hereditary Angio Edema
Location: Centennial CO
Sponsor: Octapharma

Sex: All

Age: 2+

Code: NCT06361537

Phase 3, Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Littleton CO, Lincoln NE, Columbia MO, Austin TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase 2, Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for
Growth Hormone Deficiency (GHD)
Location: Greenwood Village CO, Centennial CO, Amarillo TX,
Sponsor: Lumos Pharma

Sex: All

Age: 3 - 11

Code: NCT06948214

Phase 3, Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Littleton CO, Colorado Springs CO, Lubbock TX,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Golden CO, Amarillo TX, Denton TX, Fort Worth TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

for
Alzheimer's Disease
Location: Colorado Springs CO, Round Rock TX, Springfield IL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 60 - 70+

Code: NCT06976203

Phase 3, Recruiting

Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control

for
Chronic Pain, Intractable Pain, Low Back Pain,
Location: Greenwood CO, Corpus Christi TX, New Orleans LA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07190807

Recruiting

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

for
Hiatal Hernia
Location: Denver CO, Austin TX, Lexington KY, Mobile AL,
Sponsor: Tela Bio Inc

Sex: All

Age: 22+

Code: NCT07070115

Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Aurora CO, Santa Fe NM, Omaha NE, Waukee IA, Dallas TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase 3, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Aurora CO, Salt Lake City UT, Jupiter FL, Goodyear AZ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Aurora CO, Columbia MO, Tyler TX, Austin TX,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: Aurora CO, Golden CO, Billings MT, Omaha NE,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

for
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases,
Location: Denver CO, Dallas TX, Iowa City IA, Houston TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06858319

Phase 3, Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Aurora CO, Salt Lake City UT, Omaha NE, Rochester MN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase 3, Recruiting

Integrated Cancer Repository for Cancer Research

for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Greenwood Village CO, North Platte NE, Hastings NE,
Sponsor: University of Nebraska

Sex: All

Age: 19 - 70+

Code: NCT02012699

Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Aurora CO, Wichita Falls TX, Tyler TX, Austin TX,
Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase 3, Recruiting

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Aurora CO, Tyler TX, Eugene OR, Nashville TN,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07520006

Phase 1, Phase 2, Recruiting

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Aurora CO, Duarte CA, Houston TX, Atlanta GA, Canton OH,
Sponsor: Nerviano Medical Sciences

Sex: All

Age: 18+

Code: NCT06549790

Phase 1, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Aurora CO, Salt Lake City UT, Lincoln NE, Westwood KS,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

Denver is a pivotal hub for clinical trials, thanks to its sturdy healthcare network and renowned medical research institutions. Prominent centers such as the University of Colorado Anschutz Medical Campus, Denver Health, and Children’s Hospital Colorado are at the forefront of groundbreaking studies focusing on areas including cancer research, neurological disorders, and chronic diseases.

Denver's strong emphasis on collaboration among healthcare providers, researchers, and community organizations fosters an environment conducive to medical advancements. By participating in clinical trials in Denver, individuals not only gain access to cutting-edge therapies but also contribute significantly to the progress of medical science.

Why choose Denver for clinical trials?

Denver boasts a diverse population which helps increase the reliability and relevance of research outcomes. The city is also home to top-tier medical research facilities known for innovative approaches to healthcare and a strong emphasis on medical breakthroughs.

Choosing to participate in a clinical trial in Denver means contributing to vital medical research while benefiting from a well-coordinated and supportive clinical research infrastructure. This environment not only promotes advancements in medical science but also provides participants with access to pioneering therapies and specialized care throughout the study.

Common conditions studied in Denver

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Denver